BIOMARIN PHARMACEUTICAL INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 17.65 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 17.65M shares, a 49.38% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 13.80M shares, a 18.12% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 16.75M shares, a 77.98% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 11.81M shares, a 14.02% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.31M shares, a 19.80% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 9.44M shares, a 42.48% decline from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 16.41M shares, a 0.46% decline from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 16.48M shares, a 20.70% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 17.65M shares 10-Q · filed 2026-08-06 | 17.50M shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 13.80M shares 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 11.31M shares 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | 16.75M shares 10-Q · filed 2025-10-28 | 11.50M shares 10-Q · filed 2025-10-28 | ||||||
| 2025-06-30 | 11.81M shares 10-Q · filed 2026-08-06 | 11.79M shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 11.69M shares 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | 9.44M shares 10-K · filed 2026-02-26 | |||||||
| 2024-09-30 | 9.41M shares 10-Q · filed 2025-10-28 | 9.26M shares 10-Q · filed 2025-10-28 | ||||||
| 2024-06-30 | 10.36M shares 10-Q · filed 2024-08-05 | 10.11M shares 10-Q · filed 2024-08-05 | ||||||
| 2024-03-31 | 10.95M shares 10-Q · filed 2024-04-26 | |||||||
| 2023-12-31 | 16.41M shares 10-K · filed 2026-02-26 | |||||||
| 2023-09-30 | 16.88M shares 10-Q · filed 2024-10-31 | 12.41M shares 10-Q · filed 2024-10-31 | ||||||
| 2023-06-30 | 13.08M shares 10-Q · filed 2024-08-05 | 12.69M shares 10-Q · filed 2024-08-05 | ||||||
| 2023-03-31 | 12.97M shares 10-Q · filed 2024-04-26 | |||||||
| 2022-12-31 | 16.48M shares 10-K · filed 2025-02-24 | |||||||
| 2022-09-30 | 20.56M shares 10-Q · filed 2023-11-02 | 13.31M shares 10-Q · filed 2023-11-02 | ||||||
| 2022-06-30 | 18.99M shares 10-Q · filed 2023-08-02 | 14.80M shares 10-Q · filed 2023-08-02 | ||||||
| 2022-03-31 | 10.93M shares 10-Q · filed 2023-04-28 | |||||||
| 2021-12-31 | 20.79M shares 10-K · filed 2024-02-26 | |||||||
| 2021-09-30 | 21.05M shares 10-Q · filed 2022-10-28 | 21.05M shares 10-Q · filed 2022-10-28 | ||||||
| 2021-06-30 | 18.50M shares 10-Q · filed 2022-08-04 | 18.31M shares 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | 18.77M shares 10-Q · filed 2022-04-29 | |||||||
| 2020-12-31 | 7.84M shares 10-K · filed 2023-02-27 | |||||||
| 2020-09-30 | 8.27M shares 10-Q · filed 2021-10-29 | 8.44M shares 10-Q · filed 2021-10-29 | ||||||
| 2020-06-30 | 25.09M shares 10-Q · filed 2021-07-30 | 21.06M shares 10-Q · filed 2021-07-30 | ||||||
| 2020-03-31 | 14.09M shares 10-Q · filed 2021-04-30 | |||||||
| 2019-12-31 | 19.96M shares 10-K · filed 2022-02-25 | |||||||
| 2019-09-30 | 13.39M shares 10-Q · filed 2020-11-06 | 20.03M shares 10-Q · filed 2020-11-06 | ||||||
| 2019-06-30 | 20.25M shares 10-Q · filed 2020-08-05 | 20.25M shares 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | 20.48M shares 10-Q · filed 2020-05-01 | |||||||
| 2018-12-31 | 19.16M shares 10-K · filed 2021-02-26 | |||||||
| 2018-09-30 | 23.48M shares 10-Q/A · filed 2019-11-04 | 23.48M shares 10-Q/A · filed 2019-11-04 | ||||||
| 2018-06-30 | 23.95M shares 10-Q · filed 2018-08-03 | 23.95M shares 10-Q · filed 2019-08-02 | ||||||
| 2018-03-31 | 24.57M shares 10-Q · filed 2019-04-29 | |||||||
| 2017-12-31 | 23.61M shares 10-K · filed 2020-02-27 | |||||||
| 2017-09-30 | 23.78M shares 10-Q · filed 2018-10-26 | 23.78M shares 10-Q · filed 2018-10-26 | ||||||
| 2017-06-30 | 20.06M shares 10-Q · filed 2018-08-03 | 20.06M shares 10-Q · filed 2018-08-03 | ||||||
| 2017-03-31 | 22.03M shares 10-Q · filed 2018-04-27 | |||||||
| 2016-12-31 | 20.95M shares 10-K · filed 2019-02-28 | 20.79M shares 10-K · filed 2017-02-27 | ||||||
| 2016-09-30 | 21.99M shares 10-Q · filed 2017-10-31 | 21.79M shares 10-Q · filed 2016-11-03 | 21.74M shares 10-Q · filed 2017-10-31 | 21.52M shares 10-Q · filed 2016-11-03 | ||||
| 2016-06-30 | 23.05M shares 10-Q · filed 2017-08-02 | 22.78M shares 10-Q · filed 2016-08-08 | 23.05M shares 10-Q · filed 2017-08-02 | 22.77M shares 10-Q · filed 2016-08-08 | ||||
| 2016-03-31 | 22.23M shares 10-Q · filed 2017-05-04 | |||||||
| 2015-12-31 | 22.13M shares 10-K · filed 2018-02-26 | 22.00M shares 10-K · filed 2016-02-29 | ||||||
| 2015-09-30 | 22.01M shares 10-Q · filed 2016-11-03 | 22.12M shares 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | 22.24M shares 10-Q · filed 2016-08-08 | 22.12M shares 10-Q · filed 2016-08-08 | ||||||
| 2015-03-31 | 22.64M shares 10-Q · filed 2016-05-02 | |||||||
| 2014-12-31 | 23.25M shares 10-K · filed 2017-02-27 | 23.10M shares 10-K · filed 2015-03-02 | ||||||
| 2014-09-30 | 12.24M shares 10-Q · filed 2015-11-02 | 24.56M shares 10-Q · filed 2015-11-02 | ||||||
| 2014-06-30 | 24.40M shares 10-Q · filed 2015-08-05 | 24.55M shares 10-Q · filed 2015-08-05 | ||||||
| 2014-03-31 | 24.99M shares 10-Q · filed 2015-05-05 | |||||||
| 2013-12-31 | 25.72M shares 10-K · filed 2016-02-29 | |||||||
| 2013-09-30 | 18.99M shares 10-Q · filed 2014-10-28 | 18.92M shares 10-Q · filed 2014-10-28 | ||||||
| 2013-06-30 | 20.78M shares 10-Q · filed 2014-07-31 | 20.93M shares 10-Q · filed 2014-07-31 | ||||||
| 2013-03-31 | 20.18M shares 10-Q · filed 2014-05-02 | |||||||
| 2012-12-31 | 32.92M shares 10-K · filed 2015-03-02 | |||||||
| 2012-09-30 | 35.16M shares 10-Q · filed 2013-10-28 | 35.11M shares 10-Q · filed 2013-10-28 | ||||||
| 2012-06-30 | 35.53M shares 10-Q · filed 2013-07-29 | 35.52M shares 10-Q · filed 2013-07-29 | ||||||
| 2012-03-31 | 34.79M shares 10-Q · filed 2013-04-29 | |||||||
| 2011-12-31 | 35.17M shares 10-K · filed 2014-02-26 | |||||||
| 2011-09-30 | 35.58M shares 10-Q · filed 2012-10-29 | 35.53M shares 10-Q · filed 2012-10-29 | ||||||
| 2011-06-30 | 37.98M shares 10-Q · filed 2012-08-02 | 37.97M shares 10-Q · filed 2012-08-02 | ||||||
| 2011-03-31 | 34.79M shares 10-Q · filed 2012-04-30 | |||||||
| 2010-12-31 | 12.73M shares 10-K · filed 2013-02-26 | |||||||
| 2010-09-30 | 13.93M shares 10-Q · filed 2011-10-31 | 13.94M shares 10-Q · filed 2011-10-31 | ||||||
| 2010-06-30 | 43.34M shares 10-Q · filed 2011-08-01 | 40.55M shares 10-Q · filed 2011-08-01 | ||||||
| 2009-12-31 | 41.09M shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |